glp-1 drugs pharmaceutical companies news 2025 Which Drug Stocks to Watch in GLP-1 weight loss drugs are

Michalaki M, Margeli T, Tsekouras A, Gogos CH, Vagenakis AG, Kyriazopoulou V

102,319,320,321 A single-center double-blind, randomized, parallel placebo-controlled study found that uric acid reduction slowed the decline of glomerular filtration rate in patients with stage 3 and 4 CKD

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

In the D-Gal + FOXO4-DRI group, mice also received D-galactose injections and, after 4 weeks, were given intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days for 4 weeks, followed by tissue collection

EllieMD cites five scientific sources on their product page